[1]. M. B. Roberfroid N.M. Delzenne 1998 Dietary fructans Ann. Rev. Nutr. 18 117–143.

[1]. M. B. Roberfroid N.M. Delzenne 1998 Dietary fructans Ann. Rev. Nutr. 18 117–143.)| false
• Search Google Scholar
• Export Citation

[2]. K. L. Mahan S. Escott-Stumps 1996 Krause's Food, Nutrition, Diet Therapy WB Saunders Philadelphia 42.

[2]. K. L. Mahan S. Escott-Stumps 1996 Krause's Food, Nutrition, Diet Therapy WB Saunders Philadelphia 42.)| false
• Search Google Scholar
• Export Citation

[3]. Crow, D.: Inulin - a comprehensive scientific review. 2000, http://members.shaw.ca/duncancrow/inulin_review.html.

[3]. Crow, D.: Inulin - a comprehensive scientific review. 2000, http://members.shaw.ca/duncancrow/inulin_review.html.)| false
• Search Google Scholar
• Export Citation

[4]. M. Antal 2004 Assessment of importance of fructans in food-hygiene (in Hungarian) Sport és Egészségtudomány 3 Suppl.1 14–17.

[4]. M. Antal 2004 Assessment of importance of fructans in food-hygiene (in Hungarian) Sport és Egészségtudomány 3 Suppl.1 14–17.)| false
• Search Google Scholar
• Export Citation

[5]. Report of Joint WHO/FAO Expert Consultation 2003 Diet, nutrition and the prevention of chronic diseases 77 88.

[5]. Report of Joint WHO/FAO Expert Consultation 2003 Diet, nutrition and the prevention of chronic diseases 77 88.)| false
• Search Google Scholar
• Export Citation

[6]. J. Fehér G. Lengyel 2006 Nutrition and cardiovascular mortality (in Hungarian) Orv. Hetil. 147 1491–1496.

[6]. J. Fehér G. Lengyel 2006 Nutrition and cardiovascular mortality (in Hungarian) Orv. Hetil. 147 1491–1496.)| false
• Search Google Scholar
• Export Citation

[7]. J. Fehér G. Lengyel 2007 Clinical utilization of combined rosiglitazone and glimepiride in the treatment of type 2 diabetes mellitus (in Hungarian) Orv. Hetil. 148 2331–2335.

[7]. J. Fehér G. Lengyel 2007 Clinical utilization of combined rosiglitazone and glimepiride in the treatment of type 2 diabetes mellitus (in Hungarian) Orv. Hetil. 148 2331–2335.)| false
• Search Google Scholar
• Export Citation

[8]. G. Pados 2006 Treatment of obesity (in Hungarian) Orv. Hetil. 145 1765–1767.

[8]. G. Pados 2006 Treatment of obesity (in Hungarian) Orv. Hetil. 145 1765–1767.)| false
• Search Google Scholar
• Export Citation

[9]. A. Juhász E. Katona Csongrádi et al.2006 Practicing physician's view on obesity (in Hungarian) Orv. Hetil. 147 579–590.

[9]. A. Juhász E. Katona Csongrádi 2006 Practicing physician's view on obesity (in Hungarian) Orv. Hetil. 147 579–590.)| false
• Search Google Scholar
• Export Citation

[10]. M.P. Kalavainen M.O. Korppi O.M. Nuutinen 2007 Clinical efficacy of group-based treatment for childhood obesity compared with routinely given individual counseling Int. J. Obes. 31 1500–1508.

[10]. M.P. Kalavainen M.O. Korppi O.M. Nuutinen 2007 Clinical efficacy of group-based treatment for childhood obesity compared with routinely given individual counseling Int. J. Obes. 31 1500–1508.)| false
• Search Google Scholar
• Export Citation

[11]. WHO: Physical status, the use and interpretation of anthropometry. WHO Technical Report Series No. 854, Geneva, 1995, 263–311, 445.

[11]. WHO: Physical status, the use and interpretation of anthropometry. WHO Technical Report Series No. 854, Geneva, 1995, 263–311, 445.)| false
• Search Google Scholar
• Export Citation

[12]. M. Antal L. Biró A. Regöly-Mérei et al.2008 Methods in the assessment of adolescent obesity in epidemiologic study (in Hungarian) Orv. Hetil. 149 51–57.

[12]. M. Antal L. Biró A. Regöly-Mérei 2008 Methods in the assessment of adolescent obesity in epidemiologic study (in Hungarian) Orv. Hetil. 149 51–57.)| false
• Search Google Scholar
• Export Citation

[13]. L. U. Monzillo O. Hamdy 2003 Evaluation of insulin sensitivity in clinical practice and in research settings Nutr. Rev. 61 397–412.

[13]. L. U. Monzillo O. Hamdy 2003 Evaluation of insulin sensitivity in clinical practice and in research settings Nutr. Rev. 61 397–412.)| false
• Search Google Scholar
• Export Citation

[14]. S. Dhuper H. W. Cohen J. Daniel et al.2007 Utility of modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study Cardiovasc. Diabetol. 6 1186–1195.

[14]. S. Dhuper H. W. Cohen J. Daniel 2007 Utility of modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study Cardiovasc. Diabetol. 6 1186–1195.)| false
• Search Google Scholar
• Export Citation

[15]. B. Strasser A. Spreitzer P. Haber 2007 Fat loss depends on energy deficit only, independently of the method for weight loss Ann. Nutr. Metab. 51 428–432.

[15]. B. Strasser A. Spreitzer P. Haber 2007 Fat loss depends on energy deficit only, independently of the method for weight loss Ann. Nutr. Metab. 51 428–432.)| false
• Search Google Scholar
• Export Citation

[16]. H. H. Ditschuneit H. I. Frier M. Flechtner-Mors 2002 Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects Eur. J. Clin. Nutr. 56 264–270.

[16]. H. H. Ditschuneit H. I. Frier M. Flechtner-Mors 2002 Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects Eur. J. Clin. Nutr. 56 264–270.)| false
• Search Google Scholar
• Export Citation

[17]. G. Assmann H. Schulte H. Funke et al.1998 The emergency of triglycerides as a significant independent risk factor in coronary artery disease Eur. Heart. J. 19 Suppl.M M8–M14.

[17]. G. Assmann H. Schulte H. Funke 1998 The emergency of triglycerides as a significant independent risk factor in coronary artery disease Eur. Heart. J. 19 Suppl.M M8–M14.)| false
• Search Google Scholar
• Export Citation

[18]. Asia Pacific Cohort Studies Collaboration 2004 Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region Circulation 110 2678–2686.

[18]. Asia Pacific Cohort Studies Collaboration 2004 Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region Circulation 110 2678–2686.)| false
• Search Google Scholar
• Export Citation

[19]. J. Luo S. W. Rizkalla C. Alamowitch et al.1996 Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism Am. J. Clin. Nutr. 63 939–945.

[19]. J. Luo S. W. Rizkalla C. Alamowitch 1996 Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism Am. J. Clin. Nutr. 63 939–945.)| false
• Search Google Scholar
• Export Citation

[20]. A. Pedersen B. Sandstrom J. M. M. Van Amelsvoort 1997 The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females Br. J. Nutr. 78 215–222.

[20]. A. Pedersen B. Sandstrom J. M. M. Van Amelsvoort 1997 The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females Br. J. Nutr. 78 215–222.)| false
• Search Google Scholar
• Export Citation

[21]. K. G. Jackson G. R. J. Taylor A. M. Clohessy et al.1999 The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle aged men and women Br. J. Nutr. 82 23–30.

[21]. K. G. Jackson G. R. J. Taylor A. M. Clohessy 1999 The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle aged men and women Br. J. Nutr. 82 23–30.)| false
• Search Google Scholar
• Export Citation

[22]. D. Letexier F. Diraison M. Beylot 2003 Addition of inulin to moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans Am. J. Clin. Nutr. 77 559–564.

[22]. D. Letexier F. Diraison M. Beylot 2003 Addition of inulin to moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans Am. J. Clin. Nutr. 77 559–564.)| false
• Search Google Scholar
• Export Citation

[23]. M. B. Roberfroid 2000 Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr. 71 1682S–1687S.

[23]. M. B. Roberfroid 2000 Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr. 71 1682S–1687S.)| false
• Search Google Scholar
• Export Citation

[24]. N. M. Delzenne C. Daubioul A. Neyrinck et al.2002 Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects Br. J. Nutr. 87 S255–S259.

[24]. N. M. Delzenne C. Daubioul A. Neyrinck 2002 Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects Br. J. Nutr. 87 S255–S259.)| false
• Search Google Scholar
• Export Citation

[25]. C. M. Williams 1999 Effects of inulin on lipid parameters in humans J. Nutr. 129 1471S–1473S.

[25]. C. M. Williams 1999 Effects of inulin on lipid parameters in humans J. Nutr. 129 1471S–1473S.)| false
• Search Google Scholar
• Export Citation

[26]. B. R. Balcázar-Muñoz E. MartÍnez-Abundis M. Gonzáles-Ortiz 2003 Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia Rev. Med. Chil. 131 597–604.

[26]. B. R. Balcázar-Muñoz E. MartÍnez-Abundis M. Gonzáles-Ortiz 2003 Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia Rev. Med. Chil. 131 597–604.)| false
• Search Google Scholar
• Export Citation

[27]. K. Yamashita K. Kawai J. Itakura 1984 Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetic subjects Nutr. Res. 4 961–966.

[27]. K. Yamashita K. Kawai J. Itakura 1984 Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetic subjects Nutr. Res. 4 961–966.)| false
• Search Google Scholar
• Export Citation

[28]. M. S. Alles N. M. de Roos J. C. Bakx et al.1999 Consumption of fructooligosaccharides does not favourably affect blood glucose and serum lipid concentration in patients with type II diabetes Am. J. Clin. Nutr. 69 64–69.

[28]. M. S. Alles N. M. de Roos J. C. Bakx 1999 Consumption of fructooligosaccharides does not favourably affect blood glucose and serum lipid concentration in patients with type II diabetes Am. J. Clin. Nutr. 69 64–69.)| false
• Search Google Scholar
• Export Citation

[29]. Ahima, R. S., Lazar, M. A.: Adipokines and the peripheral and neural control of energy balance. Mol. Edocrinol., 2008, Jan 17, doi:10./me.2007-0529.

[29]. Ahima, R. S., Lazar, M. A.: Adipokines and the peripheral and neural control of energy balance. Mol. Edocrinol., 2008, Jan 17, doi:10./me.2007-0529.)| false
• Search Google Scholar
• Export Citation

[30]. G. Valsamakis P. G. McTernan R. Chetty et al.2004 Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines Metabolism 53 430–434.

[30]. G. Valsamakis P. G. McTernan R. Chetty 2004 Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines Metabolism 53 430–434.)| false
• Search Google Scholar
• Export Citation